News Campaigners urge NHS to drop Roche acne drug Campaigners are demanding that the NHS stop prescribing Roche’s acne drug Roaccutane (isotretinoin), claiming it can lead to erectile dysfunction and suicide.
Oncology ESMO26: Taiho Oncology on improving the lives of patients wi... Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.